19 May – 22 May 2018 in Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, Australia
Phototherapy – relevance in current dermatology practice
Update on tumours of the nail
Evidenced based medicine series: Surviving survival analysis
Nicotinamide and skin cancer chemoprevention: The jury is still out
Update in psychocutaneous medicine
Skin thinking, artificial intelligence and dermatology
Atopic dermatitis: An Australian management consensus
Superficial disease is harder to clear than infiltrative disease on the nasal tip and alar
A complex case of vulval pyoderma gangrenosum
Cutaneous Epstein Barr virus-associated diffuse large B-cell lymphoma presenting against a background of angioimmunoblastic t-cell lymphoma
A case series of 13 patients with oestrogen hypersensitivity vulvitis treated with cyproterone acetate
Intradermal testing for autoimmune progesterone dermatitis – should we be basing our diagnosis on it?
Allergic contact dermatitis to alcohol swabs masquerading as a tape allergy
Improving skin health in the South Pacific – meeting the need
Secukinumab in pregnancy: Outcomes from the global safety database
The U.K. skin cancer ‘two-week rule’ referral system: Audit to ascertain appropriate referrals at our institution
EASI-75 interpretation from a patient perspective – a phase 2b post-hoc analysis of dupilumab in adults with moderate-to-severe atopic dermatitis
2019 Dermcoll, 52ND ANNUAL SCIENTIFIC MEETING
2018 Dermcoll, 51ST ANNUAL SCIENTIFIC MEETING
